This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TTS | Ann: Tatts Bonds Quarterly Report | 21/03/19 | 0 | 71 | |||
|
|||||||
TTS | Ann: Interim Financial Report | 08/03/19 | 0 | 115 | |||
|
|||||||
TTS | Ann: Tabcorp Chief Financial Officer to retire | 13/02/19 | 0 | 69 | |||
|
|||||||
TTS | Ann: Release of Tabcorp Group 2019 half year results | 13/02/19 | 0 | 93 | |||
|
|||||||
TTS | Ann: Appointment of Company Secretary | 08/02/19 | 0 | 79 | |||
|
|||||||
TTS | Ann: Interest Payment - TTSHA | 07/01/19 | 0 | 163 | |||
|
|||||||
TTS | Ann: Tatts Bonds Quarterly Report | 14/12/18 | 0 | 148 | |||
|
|||||||
TTS | Ann: Tabcorp Investor Day Presentation | 25/10/18 | 0 | 106 | |||
|
See All Discussions